Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real-world study

J Eur Acad Dermatol Venereol. 2024 Sep 13. doi: 10.1111/jdv.20341. Online ahead of print.
No abstract available

Publication types

  • Letter